New Zealand’s misjudgment, pediatric 19A invasive pneumococcal disease surge Changed from Prevenar 13 to Synflorix in 2017…Reverted last year New Zealand has learned an expensive lesson from its national pneumococcal vaccine program. On the 17th, The Lancet Regional Health Western Pacific published the results of an observational study investigating the epidemiology of invasive…
Read More